Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Group B Streptococcus (GBS) Infection Treatment Market Size Growth Rate by Type: 2018 VS 2022 VS 2033
1.2.2 Prenatal-onset Gbs Disease
1.2.3 Early-onset Gbs Disease
1.2.4 Late-onset Gbs Disease
1.3 Market by Application
1.3.1 Global Group B Streptococcus (GBS) Infection Treatment Market Growth by Application: 2018 VS 2022 VS 2033
1.3.2 Hospital Pharmacies
1.3.3 Retail Pharmacies
1.3.4 Online Pharmacies
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Group B Streptococcus (GBS) Infection Treatment Market Perspective (2018-2033)
2.2 Group B Streptococcus (GBS) Infection Treatment Growth Trends by Region
2.2.1 Global Group B Streptococcus (GBS) Infection Treatment Market Size by Region: 2018 VS 2022 VS 2033
2.2.2 Group B Streptococcus (GBS) Infection Treatment Historic Market Size by Region (2018-2023)
2.2.3 Group B Streptococcus (GBS) Infection Treatment Forecasted Market Size by Region (2024-2033)
2.3 Group B Streptococcus (GBS) Infection Treatment Market Dynamics
2.3.1 Group B Streptococcus (GBS) Infection Treatment Industry Trends
2.3.2 Group B Streptococcus (GBS) Infection Treatment Market Drivers
2.3.3 Group B Streptococcus (GBS) Infection Treatment Market Challenges
2.3.4 Group B Streptococcus (GBS) Infection Treatment Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Group B Streptococcus (GBS) Infection Treatment Players by Revenue
3.1.1 Global Top Group B Streptococcus (GBS) Infection Treatment Players by Revenue (2018-2023)
3.1.2 Global Group B Streptococcus (GBS) Infection Treatment Revenue Market Share by Players (2018-2023)
3.2 Global Group B Streptococcus (GBS) Infection Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Group B Streptococcus (GBS) Infection Treatment Revenue
3.4 Global Group B Streptococcus (GBS) Infection Treatment Market Concentration Ratio
3.4.1 Global Group B Streptococcus (GBS) Infection Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Group B Streptococcus (GBS) Infection Treatment Revenue in 2022
3.5 Group B Streptococcus (GBS) Infection Treatment Key Players Head office and Area Served
3.6 Key Players Group B Streptococcus (GBS) Infection Treatment Product Solution and Service
3.7 Date of Enter into Group B Streptococcus (GBS) Infection Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Group B Streptococcus (GBS) Infection Treatment Breakdown Data by Type
4.1 Global Group B Streptococcus (GBS) Infection Treatment Historic Market Size by Type (2018-2023)
4.2 Global Group B Streptococcus (GBS) Infection Treatment Forecasted Market Size by Type (2024-2033)
5 Group B Streptococcus (GBS) Infection Treatment Breakdown Data by Application
5.1 Global Group B Streptococcus (GBS) Infection Treatment Historic Market Size by Application (2018-2023)
5.2 Global Group B Streptococcus (GBS) Infection Treatment Forecasted Market Size by Application (2024-2033)
6 North America
6.1 North America Group B Streptococcus (GBS) Infection Treatment Market Size (2018-2033)
6.2 North America Group B Streptococcus (GBS) Infection Treatment Market Growth Rate by Country: 2018 VS 2022 VS 2033
6.3 North America Group B Streptococcus (GBS) Infection Treatment Market Size by Country (2018-2023)
6.4 North America Group B Streptococcus (GBS) Infection Treatment Market Size by Country (2024-2033)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Group B Streptococcus (GBS) Infection Treatment Market Size (2018-2033)
7.2 Europe Group B Streptococcus (GBS) Infection Treatment Market Growth Rate by Country: 2018 VS 2022 VS 2033
7.3 Europe Group B Streptococcus (GBS) Infection Treatment Market Size by Country (2018-2023)
7.4 Europe Group B Streptococcus (GBS) Infection Treatment Market Size by Country (2024-2033)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Group B Streptococcus (GBS) Infection Treatment Market Size (2018-2033)
8.2 Asia-Pacific Group B Streptococcus (GBS) Infection Treatment Market Growth Rate by Region: 2018 VS 2022 VS 2033
8.3 Asia-Pacific Group B Streptococcus (GBS) Infection Treatment Market Size by Region (2018-2023)
8.4 Asia-Pacific Group B Streptococcus (GBS) Infection Treatment Market Size by Region (2024-2033)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Group B Streptococcus (GBS) Infection Treatment Market Size (2018-2033)
9.2 Latin America Group B Streptococcus (GBS) Infection Treatment Market Growth Rate by Country: 2018 VS 2022 VS 2033
9.3 Latin America Group B Streptococcus (GBS) Infection Treatment Market Size by Country (2018-2023)
9.4 Latin America Group B Streptococcus (GBS) Infection Treatment Market Size by Country (2024-2033)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Group B Streptococcus (GBS) Infection Treatment Market Size (2018-2033)
10.2 Middle East & Africa Group B Streptococcus (GBS) Infection Treatment Market Growth Rate by Country: 2018 VS 2022 VS 2033
10.3 Middle East & Africa Group B Streptococcus (GBS) Infection Treatment Market Size by Country (2018-2023)
10.4 Middle East & Africa Group B Streptococcus (GBS) Infection Treatment Market Size by Country (2024-2033)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Pfizer Inc.
11.1.1 Pfizer Inc. Company Detail
11.1.2 Pfizer Inc. Business Overview
11.1.3 Pfizer Inc. Group B Streptococcus (GBS) Infection Treatment Introduction
11.1.4 Pfizer Inc. Revenue in Group B Streptococcus (GBS) Infection Treatment Business (2018-2023)
11.1.5 Pfizer Inc. Recent Development
11.2 Alopexx Enterprises, LLC
11.2.1 Alopexx Enterprises, LLC Company Detail
11.2.2 Alopexx Enterprises, LLC Business Overview
11.2.3 Alopexx Enterprises, LLC Group B Streptococcus (GBS) Infection Treatment Introduction
11.2.4 Alopexx Enterprises, LLC Revenue in Group B Streptococcus (GBS) Infection Treatment Business (2018-2023)
11.2.5 Alopexx Enterprises, LLC Recent Development
11.3 Wellstat Vaccines LLC
11.3.1 Wellstat Vaccines LLC Company Detail
11.3.2 Wellstat Vaccines LLC Business Overview
11.3.3 Wellstat Vaccines LLC Group B Streptococcus (GBS) Infection Treatment Introduction
11.3.4 Wellstat Vaccines LLC Revenue in Group B Streptococcus (GBS) Infection Treatment Business (2018-2023)
11.3.5 Wellstat Vaccines LLC Recent Development
11.4 Minervax ApS
11.4.1 Minervax ApS Company Detail
11.4.2 Minervax ApS Business Overview
11.4.3 Minervax ApS Group B Streptococcus (GBS) Infection Treatment Introduction
11.4.4 Minervax ApS Revenue in Group B Streptococcus (GBS) Infection Treatment Business (2018-2023)
11.4.5 Minervax ApS Recent Development
11.5 Novartis
11.5.1 Novartis Company Detail
11.5.2 Novartis Business Overview
11.5.3 Novartis Group B Streptococcus (GBS) Infection Treatment Introduction
11.5.4 Novartis Revenue in Group B Streptococcus (GBS) Infection Treatment Business (2018-2023)
11.5.5 Novartis Recent Development
11.6 GlaxoSmithKline
11.6.1 GlaxoSmithKline Company Detail
11.6.2 GlaxoSmithKline Business Overview
11.6.3 GlaxoSmithKline Group B Streptococcus (GBS) Infection Treatment Introduction
11.6.4 GlaxoSmithKline Revenue in Group B Streptococcus (GBS) Infection Treatment Business (2018-2023)
11.6.5 GlaxoSmithKline Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global Group B Streptococcus (GBS) Infection Treatment Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2033
Table 2. Key Players of Prenatal-onset Gbs Disease
Table 3. Key Players of Early-onset Gbs Disease
Table 4. Key Players of Late-onset Gbs Disease
Table 5. Global Group B Streptococcus (GBS) Infection Treatment Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2033
Table 6. Global Group B Streptococcus (GBS) Infection Treatment Market Size by Region (US$ Million): 2018 VS 2022 VS 2033
Table 7. Global Group B Streptococcus (GBS) Infection Treatment Market Size by Region (2018-2023) & (US$ Million)
Table 8. Global Group B Streptococcus (GBS) Infection Treatment Market Share by Region (2018-2023)
Table 9. Global Group B Streptococcus (GBS) Infection Treatment Forecasted Market Size by Region (2024-2033) & (US$ Million)
Table 10. Global Group B Streptococcus (GBS) Infection Treatment Market Share by Region (2024-2033)
Table 11. Group B Streptococcus (GBS) Infection Treatment Market Trends
Table 12. Group B Streptococcus (GBS) Infection Treatment Market Drivers
Table 13. Group B Streptococcus (GBS) Infection Treatment Market Challenges
Table 14. Group B Streptococcus (GBS) Infection Treatment Market Restraints
Table 15. Global Group B Streptococcus (GBS) Infection Treatment Revenue by Players (2018-2023) & (US$ Million)
Table 16. Global Group B Streptococcus (GBS) Infection Treatment Market Share by Players (2018-2023)
Table 17. Global Top Group B Streptococcus (GBS) Infection Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Group B Streptococcus (GBS) Infection Treatment as of 2022)
Table 18. Ranking of Global Top Group B Streptococcus (GBS) Infection Treatment Companies by Revenue (US$ Million) in 2022
Table 19. Global 5 Largest Players Market Share by Group B Streptococcus (GBS) Infection Treatment Revenue (CR5 and HHI) & (2018-2023)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Group B Streptococcus (GBS) Infection Treatment Product Solution and Service
Table 22. Date of Enter into Group B Streptococcus (GBS) Infection Treatment Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Group B Streptococcus (GBS) Infection Treatment Market Size by Type (2018-2023) & (US$ Million)
Table 25. Global Group B Streptococcus (GBS) Infection Treatment Revenue Market Share by Type (2018-2023)
Table 26. Global Group B Streptococcus (GBS) Infection Treatment Forecasted Market Size by Type (2024-2033) & (US$ Million)
Table 27. Global Group B Streptococcus (GBS) Infection Treatment Revenue Market Share by Type (2024-2033)
Table 28. Global Group B Streptococcus (GBS) Infection Treatment Market Size by Application (2018-2023) & (US$ Million)
Table 29. Global Group B Streptococcus (GBS) Infection Treatment Revenue Market Share by Application (2018-2023)
Table 30. Global Group B Streptococcus (GBS) Infection Treatment Forecasted Market Size by Application (2024-2033) & (US$ Million)
Table 31. Global Group B Streptococcus (GBS) Infection Treatment Revenue Market Share by Application (2024-2033)
Table 32. North America Group B Streptococcus (GBS) Infection Treatment Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 33. North America Group B Streptococcus (GBS) Infection Treatment Market Size by Country (2018-2023) & (US$ Million)
Table 34. North America Group B Streptococcus (GBS) Infection Treatment Market Size by Country (2024-2033) & (US$ Million)
Table 35. Europe Group B Streptococcus (GBS) Infection Treatment Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 36. Europe Group B Streptococcus (GBS) Infection Treatment Market Size by Country (2018-2023) & (US$ Million)
Table 37. Europe Group B Streptococcus (GBS) Infection Treatment Market Size by Country (2024-2033) & (US$ Million)
Table 38. Asia-Pacific Group B Streptococcus (GBS) Infection Treatment Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2033
Table 39. Asia-Pacific Group B Streptococcus (GBS) Infection Treatment Market Size by Region (2018-2023) & (US$ Million)
Table 40. Asia-Pacific Group B Streptococcus (GBS) Infection Treatment Market Size by Region (2024-2033) & (US$ Million)
Table 41. Latin America Group B Streptococcus (GBS) Infection Treatment Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 42. Latin America Group B Streptococcus (GBS) Infection Treatment Market Size by Country (2018-2023) & (US$ Million)
Table 43. Latin America Group B Streptococcus (GBS) Infection Treatment Market Size by Country (2024-2033) & (US$ Million)
Table 44. Middle East & Africa Group B Streptococcus (GBS) Infection Treatment Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 45. Middle East & Africa Group B Streptococcus (GBS) Infection Treatment Market Size by Country (2018-2023) & (US$ Million)
Table 46. Middle East & Africa Group B Streptococcus (GBS) Infection Treatment Market Size by Country (2024-2033) & (US$ Million)
Table 47. Pfizer Inc. Company Detail
Table 48. Pfizer Inc. Business Overview
Table 49. Pfizer Inc. Group B Streptococcus (GBS) Infection Treatment Product
Table 50. Pfizer Inc. Revenue in Group B Streptococcus (GBS) Infection Treatment Business (2018-2023) & (US$ Million)
Table 51. Pfizer Inc. Recent Development
Table 52. Alopexx Enterprises, LLC Company Detail
Table 53. Alopexx Enterprises, LLC Business Overview
Table 54. Alopexx Enterprises, LLC Group B Streptococcus (GBS) Infection Treatment Product
Table 55. Alopexx Enterprises, LLC Revenue in Group B Streptococcus (GBS) Infection Treatment Business (2018-2023) & (US$ Million)
Table 56. Alopexx Enterprises, LLC Recent Development
Table 57. Wellstat Vaccines LLC Company Detail
Table 58. Wellstat Vaccines LLC Business Overview
Table 59. Wellstat Vaccines LLC Group B Streptococcus (GBS) Infection Treatment Product
Table 60. Wellstat Vaccines LLC Revenue in Group B Streptococcus (GBS) Infection Treatment Business (2018-2023) & (US$ Million)
Table 61. Wellstat Vaccines LLC Recent Development
Table 62. Minervax ApS Company Detail
Table 63. Minervax ApS Business Overview
Table 64. Minervax ApS Group B Streptococcus (GBS) Infection Treatment Product
Table 65. Minervax ApS Revenue in Group B Streptococcus (GBS) Infection Treatment Business (2018-2023) & (US$ Million)
Table 66. Minervax ApS Recent Development
Table 67. Novartis Company Detail
Table 68. Novartis Business Overview
Table 69. Novartis Group B Streptococcus (GBS) Infection Treatment Product
Table 70. Novartis Revenue in Group B Streptococcus (GBS) Infection Treatment Business (2018-2023) & (US$ Million)
Table 71. Novartis Recent Development
Table 72. GlaxoSmithKline Company Detail
Table 73. GlaxoSmithKline Business Overview
Table 74. GlaxoSmithKline Group B Streptococcus (GBS) Infection Treatment Product
Table 75. GlaxoSmithKline Revenue in Group B Streptococcus (GBS) Infection Treatment Business (2018-2023) & (US$ Million)
Table 76. GlaxoSmithKline Recent Development
Table 77. Research Programs/Design for This Report
Table 78. Key Data Information from Secondary Sources
Table 79. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Group B Streptococcus (GBS) Infection Treatment Market Size Comparison by Type (2023-2033) & (US$ Million)
Figure 2. Global Group B Streptococcus (GBS) Infection Treatment Market Share by Type: 2022 VS 2033
Figure 3. Prenatal-onset Gbs Disease Features
Figure 4. Early-onset Gbs Disease Features
Figure 5. Late-onset Gbs Disease Features
Figure 6. Global Group B Streptococcus (GBS) Infection Treatment Market Size Comparison by Application (2023-2033) & (US$ Million)
Figure 7. Global Group B Streptococcus (GBS) Infection Treatment Market Share by Application: 2022 VS 2033
Figure 8. Hospital Pharmacies Case Studies
Figure 9. Retail Pharmacies Case Studies
Figure 10. Online Pharmacies Case Studies
Figure 11. Group B Streptococcus (GBS) Infection Treatment Report Years Considered
Figure 12. Global Group B Streptococcus (GBS) Infection Treatment Market Size (US$ Million), Year-over-Year: 2018-2033
Figure 13. Global Group B Streptococcus (GBS) Infection Treatment Market Size, (US$ Million), 2018 VS 2022 VS 2033
Figure 14. Global Group B Streptococcus (GBS) Infection Treatment Market Share by Region: 2022 VS 2033
Figure 15. Global Group B Streptococcus (GBS) Infection Treatment Market Share by Players in 2022
Figure 16. Global Top Group B Streptococcus (GBS) Infection Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Group B Streptococcus (GBS) Infection Treatment as of 2022)
Figure 17. The Top 10 and 5 Players Market Share by Group B Streptococcus (GBS) Infection Treatment Revenue in 2022
Figure 18. North America Group B Streptococcus (GBS) Infection Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 19. North America Group B Streptococcus (GBS) Infection Treatment Market Share by Country (2018-2033)
Figure 20. United States Group B Streptococcus (GBS) Infection Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 21. Canada Group B Streptococcus (GBS) Infection Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 22. Europe Group B Streptococcus (GBS) Infection Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 23. Europe Group B Streptococcus (GBS) Infection Treatment Market Share by Country (2018-2033)
Figure 24. Germany Group B Streptococcus (GBS) Infection Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 25. France Group B Streptococcus (GBS) Infection Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 26. U.K. Group B Streptococcus (GBS) Infection Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 27. Italy Group B Streptococcus (GBS) Infection Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 28. Russia Group B Streptococcus (GBS) Infection Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 29. Nordic Countries Group B Streptococcus (GBS) Infection Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 30. Asia-Pacific Group B Streptococcus (GBS) Infection Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 31. Asia-Pacific Group B Streptococcus (GBS) Infection Treatment Market Share by Region (2018-2033)
Figure 32. China Group B Streptococcus (GBS) Infection Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 33. Japan Group B Streptococcus (GBS) Infection Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 34. South Korea Group B Streptococcus (GBS) Infection Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 35. Southeast Asia Group B Streptococcus (GBS) Infection Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 36. India Group B Streptococcus (GBS) Infection Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 37. Australia Group B Streptococcus (GBS) Infection Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 38. Latin America Group B Streptococcus (GBS) Infection Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 39. Latin America Group B Streptococcus (GBS) Infection Treatment Market Share by Country (2018-2033)
Figure 40. Mexico Group B Streptococcus (GBS) Infection Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 41. Brazil Group B Streptococcus (GBS) Infection Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 42. Middle East & Africa Group B Streptococcus (GBS) Infection Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 43. Middle East & Africa Group B Streptococcus (GBS) Infection Treatment Market Share by Country (2018-2033)
Figure 44. Turkey Group B Streptococcus (GBS) Infection Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 45. Saudi Arabia Group B Streptococcus (GBS) Infection Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 46. Pfizer Inc. Revenue Growth Rate in Group B Streptococcus (GBS) Infection Treatment Business (2018-2023)
Figure 47. Alopexx Enterprises, LLC Revenue Growth Rate in Group B Streptococcus (GBS) Infection Treatment Business (2018-2023)
Figure 48. Wellstat Vaccines LLC Revenue Growth Rate in Group B Streptococcus (GBS) Infection Treatment Business (2018-2023)
Figure 49. Minervax ApS Revenue Growth Rate in Group B Streptococcus (GBS) Infection Treatment Business (2018-2023)
Figure 50. Novartis Revenue Growth Rate in Group B Streptococcus (GBS) Infection Treatment Business (2018-2023)
Figure 51. GlaxoSmithKline Revenue Growth Rate in Group B Streptococcus (GBS) Infection Treatment Business (2018-2023)
Figure 52. Bottom-up and Top-down Approaches for This Report
Figure 53. Data Triangulation
Figure 54. Key Executives Interviewed